**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 6313-37-7 |Benzenamine, 2,5-Dimethoxy-4-Nitro- | 98+ | 228-640-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and in contact with skin.The toxicological
properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological
properties of this substance have not been fully investigated.
Methemoglobinemia is characterized by dizziness, drowsiness,
headache, shortness of breath, cyanosis (bluish discoloration of skin
due to deficient oxygenation of the blood), rapid heart rate and
chocolate-brown colored blood. Overexposure may cause
methemoglobinemia.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated. Methemoglobinemia
is characterized by dizziness, drowsiness, headache, shortness of
breath, cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), rapid heart rate and chocolate-brown
blood. Inhalation of aniline causes anoxia due to the formation of
methemoglobin.
Chronic:
May cause methemoglobinemia, which is characterized by
chocolate-brown colored blood, headache, weakness, dizziness, breath
shortness, cyanosis (bluish skin due to deficient oxygenation of
blood), rapid heart rate, unconsciousness and possible death.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
For methemoglobinemia, administer oxygen alone or with Methylene
Blue depending on the methemoglobin concentration in the blood.
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Vapors may
be heavier than air. They can spread along the ground and collect
in low or confined areas. Containers may explode when heated.
Non-combustible, substance itself does not burn but may decompose
upon heating to produce irritating, corrosive and/or toxic fumes.
Extinguishing Media:
Do NOT get water inside containers. For small fires, use dry
chemical, carbon dioxide, or water spray. For large fires, use dry
chemical, carbon dioxide, alcohol-resistant foam, or water spray.
Cool containers with flooding quantities of water until well after
fire is out.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 6313-37-7:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: dark khaki
Odor: aniline-like
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 152.00 - 155.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H10N2O4
Molecular Weight: 198.18
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 6313-37-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Benzenamine, 2,5-Dimethoxy-4-Nitro- -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21 Harmful by inhalation and in contact with
skin.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 6313-37-7: No information available.
Canada
CAS# 6313-37-7 is listed on Canada's NDSL List.
CAS# 6313-37-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 6313-37-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2,2,6,6-Tetramethyl-4-Piperidinol, 99%
| 2403-88-5 |
|
S-(+)-2-Pentanol, 98+%
| 26184-62-3 |
|
5-Amino-1,3,4-thiadiazole-2-thiol, 98%
| 2349-67-9 |
|
Tetrabromophenolphthalein Ethyl Ester, Reagent ACS, 95+% (UV-VIS)
| 1176-74-5 |
|
1,1,1,3,3,3-Hexafluoroisopropanol-d2, 99+ atom% d
| 38701-74-5 |
|
4-(Trifluoromethoxy)benzoic acid, 99% (titr.)
| 330-12-1 |
|
Digoxin, 95.0 to 101.0% (HPLC), Calculated on a Dry Basis
| 20830-75-5 |
|
6-Azauracil, 99%
| 461-89-2 |
|
5-Azacytidine, 99%
| 320-67-2 |
|
6-Undecanone, 97%
| 927-49-1 |
|
2-Nitrosotoluene, 97%
| 611-23-4 |
|
Guanidine sulfate, 99%
| 593-87-3 |
|
5-Bromosalicylic Acid, 98%
| 89-55-4 |
|
n-Ethylhydroxylamine hydrochloride,97%
| 42548-78-7 |
|
2,3,4,6-Tetra-o-acetyl-betha-d-glucopyranosyl azide, 98%
| 13992-25-1 |
|
Silver chromate, 99%
| 7784-01-2 |
|
1,2-O-Cyclohexylidene-3-O-Methyl-Alpha-D-Glucofuranose, 98%
| 13322-87-7 |
|
5-Bromo-2'-Deoxyuridine, 99+%
| 59-14-3 |
|
2-Chloro-4'-fluoroacetophenone, 99%
| 456-04-2 |
|
Furfuryl acetate, 99%
| 623-17-6 |
|
1,5-Anhydro-3,4,6-Tri-O-Benzyl-2-Deoxy-D-Arabinohex-1-Enitol, 99+%
| 55628-54-1 |
|
Chlorodiphenylmethane, 98%
| 90-99-3 |
|
Diethylbenzene (Techn), 90% (GC)
| 7732-18-5 |
|
2,5-Dimethoxy-4-Nitroaniline, 98+%
| 6313-37-7 |
|
7-Amino-1,3-Naphthalenedisulfonic Acid, Tech.
| 86-65-7 |
|
1,7-Diaza-12-Crown-4, 98%
| 294-92-8 |
|
n-Acetylneuraminic acid
| 131-48-6 |
|
4-Methylsulphonylbenzenesulphonyl Chloride 95%
| 82964-91-8 |
|
1,4-Naphthoquinone, 99% (UV-Vis)
| 130-15-4 |
|
Triacetin, 99%
| 102-76-1 |
|
Methyl 4-Nitrobenzoate, 99+%
| 619-50-1 |
|
Lauryl methacrylate, 65%
| 142-90-5 |
|
Palatine Fast Black Wan
| 5610-64-0 |
|
Benzyl carbamate, 99%
| 621-84-1 |
|
2,2-Diethoxyacetophenone, 98%
| 6175-45-7 |
|
2-Isopropenylaniline, 98+%
| 52562-19-3 |
|
5-Methylsalicylic acid, 98%
| 89-56-5 |
|
(2R,3S)-1-Carboxy-4-Isopropyl-2,3-Dihydroxycyclohexa-4,6-Diene,
| 0-01-1 |
|
Glycinamide Hydrochloride, 98%
| 1668-10-6 |
|
L-(+)-Gulose, 98%
| 6027-89-0 |
|
2'-Chloroacetanilide, 99+%
| 533-17-5 |
|
2-Chloro-3,5-Dibromo-1-Fluorobenzene, 98%
| 0-00-1 |
|
p-Toluidine
| 106-49-0 |
|
DL-5-Methyltryptophan, 98%
| 951-55-3 |
|
Methyl disulfide, p.a.
| 624-92-0 |
|
2-Chloroadenosine hemihydrate, 97%
| 146-77-0 |
|
Diphenylacetonitrile, 99+%
| 86-29-3 |
|
1,4-Di-tert-butylbenzene, 99%
| 1012-72-2 |
|
2-Nitrobenzamide, 98%
| 610-15-1 |
|
Tetrakis(dimethylamino)ethylene, 98%
| 996-70-3 |
|
|